Burke TW - Search Results

1

Risk factors for young premenopausal women with endometrial cancer.

Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Soliman PT, et al. Among authors: burke tw. Obstet Gynecol. 2005 Mar;105(3):575-80. doi: 10.1097/01.AOG.0000154151.14516.f7. Obstet Gynecol. 2005. PMID: 15738027

2

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.

Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, Lynch H, Lynch P, Broaddus RR. Lu KH, et al. Obstet Gynecol. 2005 Mar;105(3):569-74. doi: 10.1097/01.AOG.0000154885.44002.ae. Obstet Gynecol. 2005. PMID: 15738026

3

Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.

Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH. Oh JC, et al. Among authors: burke tw. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):748-52. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159305

4

Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence.

Smiley LM, Burke TW, Silva EG, Morris M, Gershenson DM, Wharton JT. Smiley LM, et al. Among authors: burke tw. Obstet Gynecol. 1991 Feb;77(2):271-5. doi: 10.1097/00006250-199102000-00022. Obstet Gynecol. 1991. PMID: 1988891

5

Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinoma.

Burke TW, Gershenson DM. Burke TW, et al. Clin Obstet Gynecol. 1996 Sep;39(3):716-27. doi: 10.1097/00003081-199609000-00019. Clin Obstet Gynecol. 1996. PMID: 8862895 Review. No abstract available.

6

Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy.

Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: burke tw. Int J Gynecol Cancer. 2005 May-Jun;15(3):510-6. doi: 10.1111/j.1525-1438.2005.15317.x. Int J Gynecol Cancer. 2005. PMID: 15882178 Free article.

7

Practice patterns of SGO members for stage IIIA endometrial cancer.

Lee CM, Slomovitz BM, Greer M, Sharma S, Gregurich MA, Burke T, Lu KH, Ramondetta LM. Lee CM, et al. Gynecol Oncol. 2005 Jul;98(1):77-83. doi: 10.1016/j.ygyno.2005.03.033. Gynecol Oncol. 2005. PMID: 15907988

8

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: burke tw. Gynecol Oncol. 2003 Dec;91(3):463-9. doi: 10.1016/j.ygyno.2003.08.018. Gynecol Oncol. 2003. PMID: 14675663 Review.

9

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.

Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: burke tw. J Clin Oncol. 2004 Aug 1;22(15):3126-32. doi: 10.1200/JCO.2004.11.154. J Clin Oncol. 2004. PMID: 15284264

10

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.

Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: burke tw. Gynecol Oncol. 2004 Oct;95(1):32-6. doi: 10.1016/j.ygyno.2004.06.052. Gynecol Oncol. 2004. PMID: 15385107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters